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lvfycobacterium bovis bacille Calme~e Geurin (BCG) has been suggested to be an 
attractive vehicle for the delivery of various \vaccine candidates, including those for 
malaria. However, despite possessing stroqg immunoadjuvant properties, recombinant 
BCG containing these malarial epitopes fail ·to elicit significant specific 
immunogenicity in mice. One possibility for this may be the codon bias between these 
organisms: mycobacteria is G:C rich while plasmodia is A:T rich. To test this 
hypothesis, we cloned the candidate malarial epitope, the C-terminus of Plasmodium 
jalciparum merozoite surface protein-1 (MSP-lC) using assembly PCR into 
Jvfycobacterium smegmatis. This technique involved the generation of the full300bp 
fragment from 18, overlapping 40bp oligonucleotides designed in favour of 
mycobacteria codon usage. The fragment was cloned into the lvf. Leprae l8kDa gene 
driven by the mycobacterial hsp60 promoter in a plasmid designated pUS937. The 
whole hsp60118kDa!MSP-1 C cassette was then cloned into a mycobacteriai replicative 
plasmid, pUS972, to produce pUS1754. A clone (pUS1758) containing the ' native' 
homologue ofMSP-lC generated by PCR of genomic P. falciparum DNA was also 
constructed. Western blot analyses using an antibody against the 18kDa epitope 
showed that recombinants containing pUS 1754 had approximately 1 00-fold higher 
expression levels than those containing pUS 1758. Two additional clones containing 
the ' native' MSP-lC also showed low level expression as compared to the clone 
containing pUS1754. Thus overcoming codon bias for selected vaccine candidates may 
be important in increasing the level of their expression and hence could improve the 
immunogenecity of such epitopes cloned into mycobacteria. 
INTRODUCTION 
Mycobacterium bovis bacille Calmette Guerin (BCG) is currently used as a live vaccine against 
tuberculosis. 
Although its efficacy in protecting against tuberculosis is controversial, it is an attractive vehicle 
for the delivery of various candidate vaccine epitopes including those for malaria (1 ,2,3). 
This is because BCG is; 
• safe 
• cheap and easy to mass produce 
• provides long term protection 
• stimulates the cellular immune response strongly 
However, early studies showed that malarial epitopes cloned into BCG were poorly immunogenic 
(1,2). 
This may be due to low expression of such epitopes because of codon bias. 
Mycobacteria is G:C rich (-70%), while 
Plasmodia is A:T rich (-70%) 
METHODS 
To test this hypothesis, we; 
• performed 1 ; t .. t·; ( . ): a two-step PCR on equimolar concentrations of 
several oligonucleotides to produce a DNA fragment coding for the Plasmodium falciparum 
merozoite surface protein-1 C terminus (MSP-119) with mycobacterium-preferred codon 
usage 
• cloned the product into a plasmid vector, pUS937 ( ), at the Bg/11 site within the M. 
/eprae 18kDa gene driven by the hsp60 promoter; resulting in the expression of a fusion 
protein 
• re-cloned the hsp60118kDa+MSP-11s cassette from pUS937 -derived constructs into a shuttle 
vector, pUS972 ( ) to produce pUS1765 
• re-cloned the same cassette ( ) but 
a) without MSP-11e- pUS1763 
b) containing the native MSP-119 - pUS1758 
• transformed the fast growing mycobacterium, M. smegmatis with 1 OOng plasmid DNA by 
etectroporation 
• performed Western blotting using an antibody against the M. /eprae 18kDa epitope. 
RESULTS 
A previous study showed that clones of M. smegmatis carrying the native MSP-1 19 epitope 
resulted in 
• delayed growth of the transformants (6 days) 
• a reduced transformation efficiency by at least 1 G-fold from expected levels 
• very low expression when reacted with the anti-18k0a antibody in Western blotting(: 
) 
Using assembly PCI=<:, it vvas observed rhat the 
• growth of transformants improved to within the expected time (within 4 days) 
• transformation efficiency was as expected forM. smegmatis (104 cfu/f..lQ DNA) 
• level of expression of the fusion protein was increased by at least 1 00-fold in clones 
containing the synthetic MSP-119 as compared to those containing the native MSP-11s 
( ) 
CONCLUSIONS 
Bias towards mycobacterium codon usage for the cloning of A:T rich gene fragments like those 
for malaria may be an important consideration for the cloning of such epitopes into BCG. 
The use of assembly PCR is a very attractive tool for cloning synthetic DNA fragments, and is 
probably the best method for cloning composite candidate molecules coded for by genes located 
in different regions such as those for the previously described synthetic malarial vaccine, Spf66. 
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